Combination Therapies in Relapsed/Refractory AML | Aplastic Anemia & MDS International Foundation Return to top.

Combination Therapies in Relapsed/Refractory AML

Presenter(s): 
Topic(s): 
Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Wed, 05/12/2021 - 2:30pm (EDT)

Dr. Ivana Gojo, Associate Professor of Oncology at Johns Hopkins Medicine, discusses the current treatment options for patients with relapsed/refractory AML as well as some of the most promising treatment options that are in clinical trial

Share with addtoany.com.